Descriptive Epidemiology From the Research in Osteochondritis Dissecans of the Knee (ROCK) Prospective Cohort.


Journal

The American journal of sports medicine
ISSN: 1552-3365
Titre abrégé: Am J Sports Med
Pays: United States
ID NLM: 7609541

Informations de publication

Date de publication:
01 2022
Historique:
pubmed: 25 11 2021
medline: 28 1 2022
entrez: 24 11 2021
Statut: ppublish

Résumé

Osteochondritis dissecans (OCD) occurs most commonly in the knees of young individuals. This condition is known to cause pain and discomfort in the knee and can lead to disability and early knee osteoarthritis. The cause is not well understood, and treatment plans are not well delineated. The Research in Osteochondritis Dissecans of the Knee (ROCK) group established a multicenter, prospective cohort to better understand this disease. To provide a baseline report of the ROCK multicenter prospective cohort and present a descriptive analysis of baseline data for patient characteristics, lesion characteristics, and clinical findings of the first 1000 cases enrolled into the prospective cohort. Cross-sectional study; Level of evidence, 3. Patients were recruited from centers throughout the United States. Baseline data were obtained for patient characteristics, sports participation, patient-reported measures of functional capabilities and limitations, physical examination, diagnostic imaging results, and initial treatment plan. Descriptive statistics were completed for all outcomes of interest. As of November 2020, a total of 27 orthopaedic surgeons from 17 institutions had enrolled 1004 knees with OCD, representing 903 patients (68.9% males; median age, 13.1 years; range, 6.3-25.4 years), into the prospective cohort. Lesions were located on the medial femoral condyle (66.2%), lateral femoral condyle (18.1%), trochlea (9.5%), patella (6.0%), and tibial plateau (0.2%). Most cases involved multisport athletes (68.1%), with the most common primary sport being basketball for males (27.3% of cases) and soccer for females (27.6% of cases). The median Pediatric International Knee Documentation Committee (Pedi-IKCD) score was 59.9 (IQR, 45.6-73.9), and the median Pediatric Functional Activity Brief Scale (Pedi-FABS) score was 21.0 (IQR, 5.0-28.0). Initial treatments were surgical intervention (55.4%) and activity restriction (44.0%). When surgery was performed, surgeons deemed the lesion to be stable at intraoperative assessment in 48.1% of cases. The multicenter ROCK group has been able to enroll the largest knee OCD cohort to date. This information is being used to further understand the pathology of OCD, including its cause, associated comorbidities, and initial presentation and symptoms. The cohort having been established is now being followed longitudinally to better define and elucidate the best treatment algorithms based on these presenting signs and symptoms.

Sections du résumé

BACKGROUND
Osteochondritis dissecans (OCD) occurs most commonly in the knees of young individuals. This condition is known to cause pain and discomfort in the knee and can lead to disability and early knee osteoarthritis. The cause is not well understood, and treatment plans are not well delineated. The Research in Osteochondritis Dissecans of the Knee (ROCK) group established a multicenter, prospective cohort to better understand this disease.
PURPOSE
To provide a baseline report of the ROCK multicenter prospective cohort and present a descriptive analysis of baseline data for patient characteristics, lesion characteristics, and clinical findings of the first 1000 cases enrolled into the prospective cohort.
STUDY DESIGN
Cross-sectional study; Level of evidence, 3.
METHODS
Patients were recruited from centers throughout the United States. Baseline data were obtained for patient characteristics, sports participation, patient-reported measures of functional capabilities and limitations, physical examination, diagnostic imaging results, and initial treatment plan. Descriptive statistics were completed for all outcomes of interest.
RESULTS
As of November 2020, a total of 27 orthopaedic surgeons from 17 institutions had enrolled 1004 knees with OCD, representing 903 patients (68.9% males; median age, 13.1 years; range, 6.3-25.4 years), into the prospective cohort. Lesions were located on the medial femoral condyle (66.2%), lateral femoral condyle (18.1%), trochlea (9.5%), patella (6.0%), and tibial plateau (0.2%). Most cases involved multisport athletes (68.1%), with the most common primary sport being basketball for males (27.3% of cases) and soccer for females (27.6% of cases). The median Pediatric International Knee Documentation Committee (Pedi-IKCD) score was 59.9 (IQR, 45.6-73.9), and the median Pediatric Functional Activity Brief Scale (Pedi-FABS) score was 21.0 (IQR, 5.0-28.0). Initial treatments were surgical intervention (55.4%) and activity restriction (44.0%). When surgery was performed, surgeons deemed the lesion to be stable at intraoperative assessment in 48.1% of cases.
CONCLUSION
The multicenter ROCK group has been able to enroll the largest knee OCD cohort to date. This information is being used to further understand the pathology of OCD, including its cause, associated comorbidities, and initial presentation and symptoms. The cohort having been established is now being followed longitudinally to better define and elucidate the best treatment algorithms based on these presenting signs and symptoms.

Identifiants

pubmed: 34818065
doi: 10.1177/03635465211057103
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

118-127

Subventions

Organisme : NIAMS NIH HHS
ID : R01 AR070020
Pays : United States

Auteurs

Carl W Nissen (CW)

PRISM Sports Medicine, Hartford, Connecticut; Hartford Healthcare's Bone and Joint Institute, Hartford, Connecticut, USA.

Jay C Albright (JC)

Children's Hospital Colorado, Aurora, Colorado, USA.

Christian N Anderson (CN)

Tennessee Orthopaedic Alliance, Nashville, Tennessee, USA.

Michael T Busch (MT)

Children's Healthcare of Atlanta, Atlanta, Georgia, USA.

Cathy Carlson (C)

College of Veterinary Medicine, University of Minnesota, St. Paul, Minnesota, USA.

Sasha Carsen (S)

Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.

Henry G Chambers (HG)

Rady Children's Hospital and UC San Diego, San Diego, California, USA.

Eric W Edmonds (EW)

Rady Children's Hospital and UC San Diego, San Diego, California, USA.

Jutta M Ellermann (JM)

University of Minnesota, Minneapolis, Minnesota, USA.

Henry B Ellis (HB)

Scottish Rite for Children Sports Medicine, Frisco, Texas, USA.

John B Erickson (JB)

Children's Hospital of Wisconsin, Greenfield, Wisconsin, USA.

Peter D Fabricant (PD)

Hospital for Special Surgery, New York, New York, USA.

Theodore J Ganley (TJ)

The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Daniel W Green (DW)

Hospital for Special Surgery, New York, New York, USA.

Nathan L Grimm (NL)

Idaho Sports Medicine Institute, Boise, Idaho, USA.

Benton E Heyworth (BE)

Boston Children's Hospital, Boston, Massachusetts, USA.

James Hui Hoi Po (JHH)

National University of Singapore, Singapore.

Mininder S Kocher (MS)

Boston Children's Hospital, Boston, Massachusetts, USA.

Regina O Kostyun (RO)

Hartford Healthcare's Bone and Joint Institute, Hartford, Connecticut, USA.

Aaron J Krych (AJ)

Mayo Clinic, Rochester, Minnesota, USA.

Kevin H Latz (KH)

Children's Mercy, Kansas City, Missouri, USA.

Dustin M Loveland (DM)

Children's Health Andrews Institute, Plano, Texas, USA.

Roger M Lyon (RM)

Children's Hospital of Wisconsin, Milwaukee, Wisconsin, USA.

Stephanie W Mayer (SW)

Children's Hospital Colorado, Aurora, Colorado, USA.

Norbert M Meenen (NM)

Asklepios Hospital St. George, Children's Sports Medicine, Hamburg, Germany.

Matthew D Milewski (MD)

Boston Children's Hospital, Boston, Massachusetts, USA.

Gregory D Myer (GD)

Emory Sport Performance and Research Center, Flowery Branch, Georgia; Emory Sports Medicine Center, Atlanta, Georgia; Department of Orthopaedics, Emory University School of Medicine, Atlanta, Georgia, USA.

Bradley J Nelson (BJ)

University of Minnesota, Minneapolis, Minnesota, USA.

Jeffrey J Nepple (JJ)

Washington University School of Medicine, St. Louis, Missouri, USA.

Jie C Nguyen (JC)

The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

J Lee Pace (JL)

Andrew's Institute, Children's Health, Plano, Texas, USA.

Mark V Paterno (MV)

Cincinnati Children's Hospital and University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Andrew T Pennock (AT)

Rady Children's Hospital and UC San Diego, San Diego, California, USA.

Crystal A Perkins (CA)

Children's Healthcare of Atlanta, Atlanta, Georgia, USA.

John D Polousky (JD)

Akron Children's Hospital Department of Orthopedics, Akron, Ohio, USA.

Paul Saluan (P)

Cleveland Clinic, Cleveland, Ohio, USA.

Kevin G Shea (KG)

Stanford Children's Hospital, Sunnyvale, California, USA.

Emily Shearier (E)

Hartford Healthcare's Bone and Joint Institute, Hartford, Connecticut, USA.

Marc A Tompkins (MA)

Gillette Children's Specialty Healthcare; University of Minnesota; TRIA Orthopaedic Center, Minneapolis, Minnesota, USA.

Eric J Wall (EJ)

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Jennifer M Weiss (JM)

Southern California Permanente Medical Group, Los Angeles, California, USA.

S Clifton Willimon (SC)

Children's Healthcare of Atlanta, Atlanta, Georgia, USA.

Philip L Wilson (PL)

Scottish Rite for Children Sports Medicine, Frisco, Texas, USA.

Rick W Wright (RW)

Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Andrew M Zbojniewicz (AM)

Michigan State University; Advanced Radiology Services, Grand Rapids, Michigan, USA.

James L Carey (JL)

Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Investigation performed at multiple sites.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH